Tuesday, May 31, 2022

< + > Psychedelics Co. Silo Wellness To Acquire Dyscovry Science, Seeking To Leverage Its Govt. Partnerships

Exclusive details on Silo Wellness' proposed acquisition of Dyscovry Science, a company that, unlike most of its peers in the psychedelics space, which focus on mental health issues, is targeting a physiological condition: irritable bowel syndrome.

No comments:

Post a Comment

< + > What's behind EHR-induced clinician burnout? And how to solve it?

When evaluating electronic health record systems to minimize documentation burden, usability is always the big challenge, says one informati...